YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol: Technical Workflow Guide

What This Product Solves

YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol is a crystalline small molecule designed for the selective inhibition of hypoxia-inducible factor-1α (HIF-1α) and activation of soluble guanylyl cyclase (sGC). The compound is primarily employed to dissect hypoxia signaling, tumor angiogenesis inhibition, and cGMP-mediated processes in cancer research and vascular biology. Its dual functions allow researchers to modulate pathways central to tumor survival, growth, apoptosis, and angiogenesis, making it a cornerstone for mechanistic studies targeting hypoxic microenvironments and circulation disorders (source: product_spec).

This reagent is not appropriate for diagnostic or medical applications. Its use is limited to laboratory-based research, where precise experimental control of HIF-1α and sGC activity is required. For an in-depth comparison of advanced applications and troubleshooting, see: Harnessing YC-1: A Powerful HIF-1α Inhibitor for Cancer. For scenario-driven protocol optimization in hypoxia and cancer assays, refer to: Optimizing Hypoxia and Cancer Assays with YC-1.

Protocol Parameters

• Solubility testing | ≥30.4 mg/mL in DMSO, ≥16.2 mg/mL in ethanol | Stock solution preparation for in vitro/in vivo assays | Enables preparation of high-concentration stocks for flexible dosing; avoids precipitation during storage and use | product_spec
• Storage conditions | Room temperature (solid); avoid long-term storage of solutions | General reagent handling | Ensures compound purity and stability for reproducible results; discard old solutions to prevent degradation | product_spec
• Vehicle selection for cell-based assays | DMSO or ethanol; insoluble in water | Required for accurate delivery in cell biology workflows | Minimizes solvent-related artifacts and ensures homogeneous compound delivery to cells | product_spec
• Recommended working solution freshness | Prepare fresh solution before use; do not store for extended periods | All experimental applications | Reduces risk of compound decomposition and variability in activity | workflow_recommendation
• Concentration range for HIF-1α inhibition studies | Empirically determined per model (start low micromolar) | In vitro cancer and hypoxia signaling assays | Enables titration for optimal inhibition without cytotoxicity; start with pilot dose-response | workflow_recommendation

Workflow Setup and QC Checklist

• Prepare stock solutions in DMSO or ethanol using sterile, low-adsorption tubes to avoid loss of compound.
• Filter-sterilize solutions for cell culture applications and confirm absence of particulates by visual inspection.
• Store solid YC-1 at room temperature away from light and moisture; weigh quickly to prevent moisture uptake.
• Aliquot stocks to minimize freeze-thaw cycles and prevent repeated solvent exposure.
• When diluting to working concentrations, mix thoroughly and add to culture media immediately before use.
• Verify solvent (DMSO or ethanol) concentration does not exceed cytotoxic thresholds for your model system (typically below 0.5%).
• Include appropriate vehicle controls in all experiments to account for solvent effects.
• Monitor cell viability and proliferation during pilot runs to optimize dosing and exposure time.
• QC all batches by testing for expected inhibition of hypoxia-inducible factor 1 transcriptional activity and, if relevant, sGC activation endpoints (e.g., cGMP accumulation).

Common Failure Modes and Fixes

• Precipitation in aqueous media: YC-1 is insoluble in water. Always use DMSO or ethanol as vehicle and ensure complete dissolution before dilution. Vortex and briefly sonicate if needed.
• Loss of activity due to prolonged storage of solutions: Prepare fresh working solutions for each experiment. Discard any solutions older than 24 hours, as recommended in the product dossier.
• Batch-to-batch variability: Use high-purity YC-1 (>98%) as supplied by APExBIO and confirm compound identity by LC-MS or NMR if in-house QC is available.
• Solvent toxicity to cells: Confirm that final DMSO/ethanol concentration in culture does not exceed cytocompatible limits. Adjust stock and working dilutions accordingly.
• Unexpected lack of HIF-1α inhibition: Verify compound solubility, solution freshness, and proper dosing. Include positive controls where possible for functional readouts.

Scope and Limitations

YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol is validated for research applications targeting inhibition of hypoxia-inducible factor 1 transcriptional activity, tumor angiogenesis inhibition, and related cancer biology workflows (product_spec). Its use is supported in both in vitro and in vivo models where sGC activation or inhibition of HIF-1α is a mechanistic endpoint. The reagent is not water soluble, which limits direct use in aqueous-only protocols. Researchers should not use YC-1 for diagnostic, therapeutic, or clinical purposes. Dose-response relationships and model-specific parameters must be empirically determined, as no universal protocol is endorsed for all cell types or animal models.

Conclusion

YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol provides a reliable, high-purity reagent for probing HIF-1α and sGC-modulated pathways in cancer and vascular research. By adhering to product-specific solubility, storage, and application guidelines, researchers can achieve reproducible modulation of hypoxia signaling and related processes. For further protocol optimization and troubleshooting, APExBIO provides detailed technical documentation and supports advanced workflows for apoptosis and cancer biology research.